| title | ISBN-13 | year of publica- tion | other author(s) |
|---|---|---|---|
| Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary | 978-0-309-12088-3 | 2009 | Institute of Medicine · Board on Health Sciences Policy · Robert Giffin · Sally Robinson · Theresa Wizemann |
| Challenges for the FDA: The Future of Drug Safety: Workshop Summary | 978-0-309-10986-4 | 2007 | Institute of Medicine · Board on Health Sciences Policy |
| Enabling Precision Medicine: The Role of Genetics in Clinical Drug Development: Proceedings of a Workshop | 978-0-309-46263-1 | 2017 | Engineering, and Medicine National Academies of Sciences · Health and Medicine Division · Board on Health Sciences Policy · Roundtable on Genomics and Precision Health |
| Examining the Impact of Real-World Evidence on Medical Product Development: Proceedings of a Workshop Series | 978-0-309-48829-7 | 2019 | Engineering, and Medicine National Academies of Sciences · Health and Medicine Division · Board on Health Sciences Policy |